Brought to you by 
VASTox gets £10.45mm with private financing
06 Apr 2006
Executive Summary
VASTox (chemical genomics) brought in £10.45mm ($18.2mm) through the private placement of 5.9mm ordinary shares priced at £1.77 each (a 7% discount to market) to institutional investors. Current stockholders sold an additional 1.5mm shares.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
VASTox gets £10.45mm with private financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice